© 2004 by Oxford University Press
© 2004 Oxford University Press
CORRESPONDENCE |
Re: GranulocyteMacrophage Colony-Stimulating Factor Gene-Modified Autologous Tumor Vaccines in NonSmall-Cell Lung Cancer
Affiliations of authors: Department of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey (KA, YO); Department of Medical Oncology, Numune Education and Research Hospital, Ankara, Turkey (OA); Department of Radiation Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey (MC); Department of Otolaryngology, Graduate School of Medicine and Dentistry, Okayama University, Shikata, Japan (MG).
Correspondence to: Kadri Altundag, MD, 8181 Fannin St., #728, Houston, TX 77054 (e-mail: drkadri@usa.net)
| The first 10% of the full text of this article appears below. |
Nemunaitis et al. (1) in their phase I/II study evaluated the feasibility, safety, and efficacy of vaccination with autologous tumor cells genetically